» Articles » PMID: 18060463

Under Utilization of Surveillance Mammography Among Older Breast Cancer Survivors

Overview
Publisher Springer
Specialty General Medicine
Date 2007 Dec 7
PMID 18060463
Citations 54
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Annual surveillance mammography is recommended for follow-up of women with a history of breast cancer. We examined surveillance mammography among breast cancer survivors who were enrolled in integrated healthcare systems.

Methods: Women in this study were 65 or older when diagnosed with early stage invasive breast cancer (N = 1,762). We assessed mammography use during 4 years of follow-up, using generalized estimating equations to account for repeated measurements.

Results: Eighty-two percent had mammograms during the first year after treatment; the percentage declined to 68.5% in the fourth year of follow-up. Controlling for age and comorbidity, women who were at higher risk of recurrence by being diagnosed at stage II or receiving breast-conserving surgery (BCS) without radiation therapy were less likely to have yearly mammograms (compared to stage I, odds ratio [OR] for stage IIA 0.72, confidence interval [CI] 0.59, 0.87, OR for stage IIB 0.75, CI 0.57, 1.0; compared to BCS with radiation, OR 0.58, CI 0.43, 0.77). Women with visits to a breast cancer surgeon or oncologist were more likely to receive mammograms (OR for breast cancer surgeon 6.0, CI 4.9, 7.4, OR for oncologist 7.4, CI 6.1, 9.0).

Conclusions: Breast cancer survivors who are at greater risk of recurrence are less likely to receive surveillance mammograms. Women without a visit to an oncologist or breast cancer surgeon during a year have particularly low rates of mammography. Improvements to surveillance care for breast cancer survivors may require active participation by primary care physicians and improvements in cancer survivorship programs by healthcare systems.

Citing Articles

Surveillance Mammography Behaviors in Black and White Breast Cancer Survivors: Behavioral Risk Factors and Surveillance System, 2016.

Edmonds M, Dahman B, Kim S, McGuire K, Sheppard V BMC Womens Health. 2023; 23(1):148.

PMID: 36997881 PMC: 10061852. DOI: 10.1186/s12905-023-02246-x.


A Mixed Method Approach to Examine Surveillance Mammography Experiences in Black and White Breast Cancer Survivors.

Edmonds M, Kim S, Wells M, Dahman B, Sheppard V Clin Breast Cancer. 2022; 22(8):801-811.

PMID: 36137937 PMC: 10194039. DOI: 10.1016/j.clbc.2022.08.009.


Adherence to the Dutch Breast Cancer Guidelines for Surveillance in Breast Cancer Survivors: Real-World Data from a Pooled Multicenter Analysis.

Draeger T, Voelkel V, Schreuder K, Veltman J, Dassen A, Strobbe L Oncologist. 2022; 27(10):e766-e773.

PMID: 35962739 PMC: 9526487. DOI: 10.1093/oncolo/oyac126.


Addressing Disparities Related to Access of Multimodality Breast Imaging Services Before and During the COVID-19 Pandemic.

Nguyen D, Ambinder E, Myers K, Oluyemi E Acad Radiol. 2022; 29(12):1852-1860.

PMID: 35562265 PMC: 8947962. DOI: 10.1016/j.acra.2022.03.017.


Adherence of long-term breast cancer survivors to follow-up care guidelines: a study based on real-world data from the SURBCAN cohort.

Santia P, Jansana A, Del Cura I, Padilla-Ruiz M, Domingo L, Louro J Breast Cancer Res Treat. 2022; 193(2):455-465.

PMID: 35290544 PMC: 9090857. DOI: 10.1007/s10549-022-06563-x.


References
1.
Khatcheressian J, Wolff A, Smith T, Grunfeld E, Muss H, Vogel V . American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting. J Clin Oncol. 2006; 24(31):5091-7. DOI: 10.1200/JCO.2006.08.8575. View

2.
Del Turco M, Palli D, Cariddi A, Ciatto S, Pacini P, Distante V . Intensive diagnostic follow-up after treatment of primary breast cancer. A randomized trial. National Research Council Project on Breast Cancer follow-up. JAMA. 1994; 271(20):1593-7. DOI: 10.1001/jama.271.20.1593. View

3.
Grunfeld E, Levine M, Julian J, Coyle D, Szechtman B, Mirsky D . Randomized trial of long-term follow-up for early-stage breast cancer: a comparison of family physician versus specialist care. J Clin Oncol. 2006; 24(6):848-55. DOI: 10.1200/JCO.2005.03.2235. View

4.
. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005; 365(9472):1687-717. DOI: 10.1016/S0140-6736(05)66544-0. View

5.
Lash T, Silliman R . Medical surveillance after breast cancer diagnosis. Med Care. 2001; 39(9):945-55. DOI: 10.1097/00005650-200109000-00005. View